Cite
Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation.
MLA
Borchert, Tobias, et al. “Angiotensin-Converting Enzyme Inhibitor Treatment Early after Myocardial Infarction Attenuates Acute Cardiac and Neuroinflammation without Effect on Chronic Neuroinflammation.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 7, July 2020, pp. 1757–68. EBSCOhost, https://doi.org/10.1007/s00259-020-04736-8.
APA
Borchert, T., Hess, A., Lukačević, M., Ross, T. L., Bengel, F. M., & Thackeray, J. T. (2020). Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation. European Journal of Nuclear Medicine and Molecular Imaging, 47(7), 1757–1768. https://doi.org/10.1007/s00259-020-04736-8
Chicago
Borchert, Tobias, Annika Hess, Mario Lukačević, Tobias L Ross, Frank M Bengel, and James T Thackeray. 2020. “Angiotensin-Converting Enzyme Inhibitor Treatment Early after Myocardial Infarction Attenuates Acute Cardiac and Neuroinflammation without Effect on Chronic Neuroinflammation.” European Journal of Nuclear Medicine and Molecular Imaging 47 (7): 1757–68. doi:10.1007/s00259-020-04736-8.